156 related articles for article (PubMed ID: 35793386)
1. Only one-third of referrals for fatty liver disease are on time: real-world study reveals opportunities to avoid unnecessary and delayed referrals.
Lindvig KP; Wernberg CW; Kjaergaard M; Thorhauge KH; Alnor AB; Thiele M; Krag A
Scand J Gastroenterol; 2022 Dec; 57(12):1478-1485. PubMed ID: 35793386
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease.
Srivastava A; Gailer R; Tanwar S; Trembling P; Parkes J; Rodger A; Suri D; Thorburn D; Sennett K; Morgan S; Tsochatzis EA; Rosenberg W
J Hepatol; 2019 Aug; 71(2):371-378. PubMed ID: 30965069
[TBL] [Abstract][Full Text] [Related]
3. Simple blood fibrosis tests reduce unnecessary referrals for specialized evaluations of liver fibrosis in NAFLD and ALD patients.
Broussier T; Lannes A; Zuberbuhler F; Oberti F; Fouchard I; Hunault G; Cales P; Boursier J
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):349-355. PubMed ID: 31422033
[TBL] [Abstract][Full Text] [Related]
4. Is there scope to improve the selection of patients with alcohol-related liver disease for referral to secondary care? A retrospective analysis of primary care referrals to a UK liver centre, incorporating simple blood tests.
Rhodes FA; Cococcia S; Patel P; Panovska-Griffiths J; Tanwar S; Westbrook RH; Rodger A; Rosenberg W
BMJ Open; 2021 Jun; 11(6):e047786. PubMed ID: 34088709
[TBL] [Abstract][Full Text] [Related]
5. Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD.
Ciardullo S; Ronchetti C; Muraca E; Oltolini A; Perra S; Bianconi E; Zerbini F; Cannistraci R; Manzoni G; Gastaldelli A; Lattuada G; Perseghin G
J Endocrinol Invest; 2020 Jul; 43(7):1019-1026. PubMed ID: 32008185
[TBL] [Abstract][Full Text] [Related]
6. Patients with type 2 diabetes and elevated fibrosis-4 are under-referred to hepatology and have unrecognized hepatic decompensation.
Dunn W; Song X; Koestler D; Grdinovac K; Al-Hihi E; Chen J; Taylor R; Wilson J; Weinman SA
J Gastroenterol Hepatol; 2022 Sep; 37(9):1815-1821. PubMed ID: 35613944
[TBL] [Abstract][Full Text] [Related]
7. Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis.
Patel PJ; Banh X; Horsfall LU; Hayward KL; Hossain F; Johnson T; Stuart KA; Brown NN; Saad N; Clouston A; Irvine KM; Russell AW; Valery PC; Williams S; Powell EE
Intern Med J; 2018 Feb; 48(2):144-151. PubMed ID: 29083080
[TBL] [Abstract][Full Text] [Related]
8. [Not Available].
Hansen CD; Lindvig KP; Grønbæk H; Gluud LL; Thiele M; Krag A
Ugeskr Laeger; 2022 Oct; 184(42):. PubMed ID: 36305262
[TBL] [Abstract][Full Text] [Related]
9. Use of standardised assessment forms in referrals to hepatology outpatient services: implications for accurate triaging of patients with chronic hepatitis C.
Horsfall L; Macdonald G; Scott I; Skoien R; Khatun M; Moss C; Seligman C; Kardash C; Poxon V; Powell EE
Aust Health Rev; 2013 May; 37(2):218-22. PubMed ID: 23448666
[TBL] [Abstract][Full Text] [Related]
10. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease.
Schwimmer JB; Newton KP; Awai HI; Choi LJ; Garcia MA; Ellis LL; Vanderwall K; Fontanesi J
Aliment Pharmacol Ther; 2013 Nov; 38(10):1267-77. PubMed ID: 24117728
[TBL] [Abstract][Full Text] [Related]
11. Decompensated cirrhosis is the commonest presentation for NAFLD patients undergoing liver transplant assessment.
Hussain A; Patel PJ; Rhodes F; Srivastava A; Patch D; Rosenberg W
Clin Med (Lond); 2020 May; 20(3):313-318. PubMed ID: 32414722
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing knee osteoarthritis in patients, differences between general practitioners and orthopedic surgeons: a retrospective cohort study.
Evers BJ; Schers HJ; van den Ende CHM; Thurlings RM; Koëter S
BMC Prim Care; 2023 Aug; 24(1):155. PubMed ID: 37528362
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the pre-referral workup for gastroenterology and hepatology specialty care: consensus using the Delphi method.
Ho CK; Boscardin CK; Gleason N; Collado D; Terdiman J; Terrault NA; Gonzales R
J Eval Clin Pract; 2016 Feb; 22(1):46-52. PubMed ID: 26223584
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria.
Sánchez-Torrijos Y; Ampuero J; Pérez Palacios D; Gallego-Durán R; Romero-Gómez M
Rev Esp Enferm Dig; 2019 Apr; 111(4):270-274. PubMed ID: 30810332
[TBL] [Abstract][Full Text] [Related]
15. [Referrals to a gastroenterology outpatient clinic from primary care: evaluation of two programs].
Quintas Lorenzo P; Dacal Rivas A; González MF; Cubiella Fernández J; López Sánchez L; García García MJ; Fernández Seara J
Gac Sanit; 2011; 25(6):468-73. PubMed ID: 21733599
[TBL] [Abstract][Full Text] [Related]
16. Promoting hospital and primary care collaboration for timely and effective care for chronic hepatitis B in western Melbourne.
Sievert K; Liddle R; Tan A; Arachchi N; Valaydon Z; Allard N
Aust Health Rev; 2020 Aug; 44(4):521-526. PubMed ID: 32718420
[TBL] [Abstract][Full Text] [Related]
17. Palliative Care and Hospice Referrals in Patients with Decompensated Cirrhosis: What Factors Are Important?
Holden JH; Shamseddeen H; Johnson AW; Byriel B; Subramoney K; Cheng YW; Saito A; Ghabril M; Chalasani N; Sachs GA; Orman ES
J Palliat Med; 2020 Aug; 23(8):1066-1075. PubMed ID: 32091954
[No Abstract] [Full Text] [Related]
18. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?
Blond E; Disse E; Cuerq C; Drai J; Valette PJ; Laville M; Thivolet C; Simon C; Caussy C
Diabetologia; 2017 Jul; 60(7):1218-1222. PubMed ID: 28352941
[TBL] [Abstract][Full Text] [Related]
19. Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease.
Srivastava A; Jong S; Gola A; Gailer R; Morgan S; Sennett K; Tanwar S; Pizzo E; O'Beirne J; Tsochatzis E; Parkes J; Rosenberg W
BMC Gastroenterol; 2019 Jul; 19(1):122. PubMed ID: 31296161
[TBL] [Abstract][Full Text] [Related]
20. Referral pathways for patients with NAFLD based on non-invasive fibrosis tests: Diagnostic accuracy and cost analysis.
Crossan C; Majumdar A; Srivastava A; Thorburn D; Rosenberg W; Pinzani M; Longworth L; Tsochatzis EA
Liver Int; 2019 Nov; 39(11):2052-2060. PubMed ID: 31332938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
